Elon Musk's Neuralink has received FDA approval to start testing its brain chip implants on paralyzed human volunteers. Announced in a company blog post, Neuralink is now looking for participants for a clinical trial aimed at assessing the safety and effectiveness of its technology.
Named "The PRIME Study," the experiment has been authorized under an Investigational Device Exemption (IDE) from the FDA as of May 2023. The company's primary aim is to enable people to control computer cursors or keyboards solely through their thoughts. To make this possible, fine threads containing electrodes will be surgically inserted into the brain region responsible for movement.
During the study, a robot called the R1 will implant the N1 chip into participants' brains. The volunteers will then use an app to control a computer and offer feedback
#Altcoin, #Bitcoin, #Blockchain, #Cryptocurrency, #Cryptomarket, #Cryptonewstoday, #News
First found on: FDA Greenlights Neuralink's Brain Chip Trials on Paralyzed Humans
Comments
Post a Comment